Unknown

Dataset Information

0

Identification of the optimal treatment regimen in the presence of missing covariates.


ABSTRACT: Covariates associated with treatment-effect heterogeneity can potentially be used to make personalized treatment recommendations towards best clinical outcomes. Methods for treatment-selection rule development that directly maximize treatment-selection benefits have attracted much interest in recent years, due to the robustness of these methods to outcome modeling. In practice, the task of treatment-selection rule development can be further complicated by missingness in data. Here, we consider the identification of optimal treatment-selection rules for a binary disease outcome when measurements of an important covariate from study participants are partly missing. Under the missing at random assumption, we develop a robust estimator of treatment-selection rules under the direct-optimization paradigm. This estimator targets the maximum selection benefits to the population under correct specification of at least one mechanism from each of the two sets-missing data or conditional covariate distribution, and treatment assignment or disease outcome model. We evaluate and compare performance of the proposed estimator with alternative direct-optimization estimators through extensive simulation studies. We demonstrate the application of the proposed method through a real data example from an Alzheimer's disease study for developing covariate combinations to guide the treatment of Alzheimer's disease.

SUBMITTER: Huang Y 

PROVIDER: S-EPMC6954309 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of the optimal treatment regimen in the presence of missing covariates.

Huang Ying Y   Zhou Xiao-Hua XH  

Statistics in medicine 20191127 4


Covariates associated with treatment-effect heterogeneity can potentially be used to make personalized treatment recommendations towards best clinical outcomes. Methods for treatment-selection rule development that directly maximize treatment-selection benefits have attracted much interest in recent years, due to the robustness of these methods to outcome modeling. In practice, the task of treatment-selection rule development can be further complicated by missingness in data. Here, we consider t  ...[more]

Similar Datasets

| S-EPMC5583003 | biostudies-literature
| S-EPMC6456380 | biostudies-literature
| S-EPMC7598794 | biostudies-literature
| S-EPMC8741149 | biostudies-literature
| S-EPMC5031948 | biostudies-literature
| S-EPMC4915613 | biostudies-literature
| S-EPMC6453121 | biostudies-literature
| S-EPMC3574968 | biostudies-literature
| S-EPMC6820681 | biostudies-literature
| S-EPMC4760115 | biostudies-literature